Literature DB >> 17629858

Long-term results after coronary artery reconstructive surgery.

V Gegouskov1, U Tochtermann, D Badowski-Zyla, G Thomas, S Hagl, B Osswald.   

Abstract

BACKGROUND: Diffuse coronary artery disease, multiple consecutive stenoses and complex lesions are a common finding in coronary surgery. Coronary reconstructive surgery in terms of extended anastomoses with or without thromboendarterectomy is still controversially discussed. The aim of this study was to evaluate the long-term results of patients who underwent coronary reconstruction.
METHODS: Between January 1995 and June 2004, 640 consecutive, unselected patients underwent isolated CABG with coronary reconstructive surgery of the LAD at a single institution. A cross-sectional long-term follow-up was performed with a completeness of 99.2 %. Questionnaires were sent to all patients with a response rate of 83.2 % (n = 533).
RESULTS: 147 of the 640 patients (22.9 %) died during up the follow-up period which was up to 10 years. Of the 371 patients who responded to the questionnaires, the status of 54 patients (15.9 %), predominantly those with a preoperative lower NYHA class, remained unchanged, while 294 patients (79.2 %) improved by at least one NYHA class. Repeat angiography was performed in 80 patients (15.7 %). Indications for percutaneous coronary intervention for the LAD arose in 4 cases (0.8 %); the interventions were performed in the proximal (n = 2) or distal (n = 1) LAD and one intervention affected the anastomotic area. Redo CABG was necessary in 3 patients (0.5 %).
CONCLUSIONS: Coronary reconstruction in patients with complex coronary morphology and advanced diffuse CAD is in an additionally investigated subgroup of patients associated with a satisfying graft patency and excellent long-term results in terms of survival, NYHA class and reintervention rate.

Entities:  

Mesh:

Year:  2007        PMID: 17629858     DOI: 10.1055/s-2007-965061

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  6 in total

1.  Reduced effects of cardiac extracorporeal shock wave therapy on angiogenesis and myocardial function recovery in patients with end-stage coronary artery and renal diseases.

Authors:  Pei-Hsun Sung; Morgan Fu; Hsin-Ju Chiang; Chi-Ruei Huang; Chi-Hsiang Chu; Mel S Lee; Hon-Kan Yip
Journal:  Biomed J       Date:  2020-10-12       Impact factor: 7.892

2.  Early results of coronary endarterectomy combined with coronary artery bypass grafting in patients with diffused coronary artery disease.

Authors:  Li-Qun Chi; Jian-Qun Zhang; Qing-Yu Kong; Wei Xiao; Lin Liang; Xin-Liang Chen
Journal:  Chin Med J (Engl)       Date:  2015-06-05       Impact factor: 2.628

3.  Baseline factors identified for the prediction of good responders in patients with end-stage diffuse coronary artery disease undergoing intracoronary CD34+ cell therapy.

Authors:  Pei-Hsun Sung; Hsin-Ju Chiang; Yi-Chen Li; John Y Chiang; Chi-Hsiang Chu; Pei-Lin Shao; Fan-Yen Lee; Mel S Lee; Hon-Kan Yip
Journal:  Stem Cell Res Ther       Date:  2020-07-29       Impact factor: 6.832

4.  Intracoronary Injection of Autologous CD34+ Cells Improves One-Year Left Ventricular Systolic Function in Patients with Diffuse Coronary Artery Disease and Preserved Cardiac Performance-A Randomized, Open-Label, Controlled Phase II Clinical Trial.

Authors:  Pei-Hsun Sung; Yi-Chen Li; Mel S Lee; Hao-Yi Hsiao; Ming-Chun Ma; Sung-Nan Pei; Hsin-Ju Chiang; Fan-Yen Lee; Hon-Kan Yip
Journal:  J Clin Med       Date:  2020-04-07       Impact factor: 4.241

5.  Coronary endarterectomy in patients with diffuse coronary artery disease: assessment of graft patency with computed tomography angiography.

Authors:  Mariam Ellouze; Denis Bouchard; Magali Pham; Pierre Emmanuel Noly; Louis P Perrault; Raymond Cartier; Michel Carrier
Journal:  Can J Surg       Date:  2022-09-21       Impact factor: 2.840

6.  Extracorporeal shock wave treatment attenuated left ventricular dysfunction and remodeling in mini-pig with cardiorenal syndrome.

Authors:  Jiunn-Jye Sheu; Hani E E Ali; Ben-Chung Cheng; Hsin-Ju Chiang; Pei-Hsun Sung; Kuan-Hung Chen; Chih-Chao Yang; Yen-Ta Chen; John Y Chiang; Pao-Yuan Lin; Sarah Chua; Han-Tan Chai; Sheng-Ying Chung; Cheuk-Kwan Sun; Hon-Kan Yip
Journal:  Oncotarget       Date:  2017-05-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.